Annual Total Liabilities
$28.66 M
+$21.27 M+287.64%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual total liabilities is $28.66 million, with the most recent change of +$21.27 million (+287.64%) on December 31, 2023.
- During the last 3 years, IMNM annual total liabilities has risen by +$25.48 million (+801.19%).
- IMNM annual total liabilities is now -29.57% below its all-time high of $40.69 million, reached on December 31, 2019.
Performance
IMNM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$41.99 M
-$385.00 K-0.91%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly total liabilities is $41.99 million, with the most recent change of -$385.00 thousand (-0.91%) on September 30, 2024.
- Over the past year, IMNM quarterly total liabilities has increased by +$13.33 million (+46.53%).
- IMNM quarterly total liabilities is now -51.78% below its all-time high of $87.08 million, reached on September 30, 2023.
Performance
IMNM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IMNM Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +287.6% | +46.5% |
| 3 y3 years | +801.2% | +468.0% |
| 5 y5 years | -3.4% | +468.0% |
IMNM Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +287.6% | -51.8% | +468.0% |
| 5 y | 5-year | -29.6% | +801.2% | -51.8% | +1241.6% |
| alltime | all time | -29.6% | +801.2% | -51.8% | +1241.6% |
Immunome Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $41.99 M(-0.9%) |
| Jun 2024 | - | $42.38 M(+24.0%) |
| Mar 2024 | - | $34.18 M(+19.3%) |
| Dec 2023 | $28.66 M(+287.6%) | $28.66 M(-67.1%) |
| Sep 2023 | - | $87.08 M(+171.3%) |
| Jun 2023 | - | $32.10 M(-6.3%) |
| Mar 2023 | - | $34.25 M(+363.3%) |
| Dec 2022 | $7.39 M | $7.39 M(-0.9%) |
| Sep 2022 | - | $7.46 M(-14.6%) |
| Jun 2022 | - | $8.74 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $9.85 M(+1.2%) |
| Dec 2021 | $9.74 M(+206.3%) | $9.74 M(+25.4%) |
| Sep 2021 | - | $7.76 M(+120.3%) |
| Jun 2021 | - | $3.52 M(-25.2%) |
| Mar 2021 | - | $4.71 M(+48.1%) |
| Dec 2020 | $3.18 M(-92.2%) | $3.18 M(-94.8%) |
| Sep 2020 | - | $61.07 M(+1851.1%) |
| Jun 2020 | - | $3.13 M(-92.3%) |
| Dec 2019 | $40.69 M(+37.2%) | $40.69 M |
| Dec 2018 | $29.65 M | - |
FAQ
- What is Immunome annual total liabilities?
- What is the all time high annual total liabilities for Immunome?
- What is Immunome annual total liabilities year-on-year change?
- What is Immunome quarterly total liabilities?
- What is the all time high quarterly total liabilities for Immunome?
- What is Immunome quarterly total liabilities year-on-year change?
What is Immunome annual total liabilities?
The current annual total liabilities of IMNM is $28.66 M
What is the all time high annual total liabilities for Immunome?
Immunome all-time high annual total liabilities is $40.69 M
What is Immunome annual total liabilities year-on-year change?
Over the past year, IMNM annual total liabilities has changed by +$21.27 M (+287.64%)
What is Immunome quarterly total liabilities?
The current quarterly total liabilities of IMNM is $41.99 M
What is the all time high quarterly total liabilities for Immunome?
Immunome all-time high quarterly total liabilities is $87.08 M
What is Immunome quarterly total liabilities year-on-year change?
Over the past year, IMNM quarterly total liabilities has changed by +$13.33 M (+46.53%)